1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Satralizumab
Trade Name:
Enspryng
Manufacturer/Distributor:
Hoffman-La Roche Limited
Classification:
Immunosuppresant
Interleukin receptor inhibitor
ATC Class:
L04AC19 - satralizumab
Status:
active
Notice of Compliance (yyyy/mm/dd):
2020/06/01
Date Marketed in Canada (yyyy/mm/dd):
2020/08/26
Presentation:
Solution for S/C injection: 120 mg/mL. DIN: 02499681
Comments:
For the treatment of neuromyelitis optica spectrum disorders.
Source:
Product monograph
Back to:
Drug Product Listings 
